# Genmab A/S: Form 20-F for the period ended Dec 31, 2019

- Company: [Genmab A/S](/companies/gmab.md) (CIK 1434265)
- Form: 20-F
- Filed: 2020-03-30
- Accepted by EDGAR: Mar 30, 2020, 17:12 ET
- Period: 2019-12-31
- Accession: 0001558370-20-003378
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434265/000155837020003378/gmab-20191231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434265/000155837020003378/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2019-01-01 to 2019-12-31 | DKK 5.37bn | ifrs-full:RevenueFromContractsWithCustomers |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434265/000155837020003378/gmab-20191231x20f.htm

Filed Mar 30, 2020.
Source: SEC EDGAR, the filing index for accession 0001558370-20-003378. Last ingested by Listed: Nov 5, 2026, 13:12 ET. No prices; not investment advice.